I am excited to share this new piece of research: patient-reported and patient-administered outcomes may be useful to assess progression independent of relapse activity in MS. Many thanks Evy Reinders @MarTintore@XMontalban@cemcat_em MS PATHS @VHIR_ https://t.co/CuFgXvu6cg
Controversy session about cures for neuroinflammatory diseases of the CNS at the @EANeurology annual meeting. Also good for networking with veteran and young colleagues alike, including meeting F2F with my @IntNatlWiMS mentee. @v_tseriotis@irenetrefrenk@ikerelosua and more.
It has been a pleasure to host you for #ECTRIMS25.
The whole @cemcat_em team wishes you a safe trip back and a restful weekend. Looking forward to seeing you in #Toronto next year (my second favourite city!)
It’s EAN time again! 🧠
Oral presentation on fluid biomarkers in MS, as part of CoCoCare’s course on Guidelines & Cost-Conscious Care, focusing on #sNfL in MS monitoring.
🔗 https://t.co/4NkHR4lmwF
Looking forward to panel meetings, new ideas & upcoming projects!🎯
#ean2025
Despite advances in diagnostic methods, 83% of countries around the world still face barriers to early MS diagnosis. These challenges exist across all income levels and regions, impacting millions of lives. That’s why the #MyMSDiagnosis campaign is calling for change. 📢✨
Check out our latest publication at Movement Disorders Clinical Practice to learn all about the swallow tail sign on susceptibility-weighted imaging across a wide spectrum of neurological disorders 🧠💪🏼
Where does the swallow tail sign apply in clinical neurology? A systematic review by Tseriotis et al. explores its clinical utility in various neurological disorders. @v_tseriotis@TheodorosMavri2 https://t.co/fRVuahZQIm
If you think the investigation for ataxia is already too broad and overwhelming, well, here's another cause. 🤷🏻
We present a case of SIADH-related hyponatremia, a condition that can rarely manifest as reversible cerebellar deficits.
#ataxia#hyponatremia
https://t.co/w7GTmWbAsZ
This new multicentre study of 113 MOGAD patients looked at impact of disease burden on cognition longitudinally. One in 10 patients (11%) showed neuropsychological deficits, which were predicted stronlgly by cerebral lesions
https://t.co/GQr7t5GZ0W @NeuroVisionLab, @pia_sperber
So proud that my new work has reached a milestone of downloads on https://t.co/yNz4M9c0JH 🧠📊📈
More importantly, a few days ago, the article was officially published in "Cognitive Neurodynamics", one of the leading journals in cognitive neuroscience! 😎
https://t.co/Wqwd50vqW1
EEG Criticality as a Cognitive Impairment Biomarker?🧠
@v_tseriotis found amnesic Mild Cognitive Impairment (aMCI) patients showed enhanced #EEG criticality in key brain areas after 6 months of memory training. This shift could be a new way for monitoring.
https://t.co/daDnDsbF1u
Join us on #eanNews to explore the @WHO IGAP Implementation Toolkit.
🧠 The webinar covers the rationale, structure, & utilization of the toolkit, along with regional perspectives on neurological care and brain health, + more!
🔗Watch the webinar now: https://t.co/IGYuFwaUhk
#NewProfilePic taken at the 10th Congress of the European Academy of Neurology 🧠
Had a blast as the RRFS Representative for the Scientific Panel of Neuroepidemiology 🌐
#EAN#neurology#neurologist
📢💡Reflecting on the most amazing neurological event, the 10th EAN Congress. Honored to 📊 present 💼 serve as chairperson 👨🏻💼 stand as the Neuroepidemiology RRFS Representative and Communication Liaison
📝 start the CoCoCare programme
Thank you, EAN! 🙏🏼 #neurology#ean